SCPX

Scorpius Holdings, Inc.

OTC · Pharmaceutical Preparations · Inc. DE · CIK 0001476963
$0.001000 0.00%
Vol
Inst. Holders4 funds
Inst. Value$67.4K
Inst. Activity0 buys / 1 sells
SEC Reports1
Exchange OTC·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001476963·Prev Close $0.001000

Recent Activity

Apr 24, 2026 SEC
Scorpius Holdings, Inc. (SCPX) announced the immediate resignation of three non-employee board members: John Monahan, Ed
8-K — Impact 6/10
Inst.
UBS Group AG — EXIT
0 shares ($0.00)
Inst.
UBS Group AG — DOUBLED
348,312 shares ($48.4K)
Apr 28, 2026 earnings_calendar
SCPX Q4 2025 Earnings After Market Close — 2026-04-28

Analyst Ratings

Historical distribution86% buy · 7 analysts · last covering-analyst action May 2023
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
May 1, 2023 Brookline Capital DOWNGRADE Buy → Hold
Apr 3, 2023 Maxim Group DOWNGRADE Buy → Hold
Mar 3, 2021 Cantor Fitzgerald INITIATE Overweight

Top Institutional Holders

FundValueMove
UBS Group AG$48.4KEXIT
CITADEL ADVISORS LLC$19.0KNEW
MORGAN STANLEY$17.00
BANK OF AMERICA CORP$6.00
4 institutional holders with $67.4K total value (485,085 shares) as of 2025-Q1. Top holders: UBS, CITADEL, MORGAN. Net buying activity: 2 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q1

#FundSharesValue% of TrackedLast Move
1UBS Group AG348,312$48.4K71.8%EXIT -100.0%
2CITADEL ADVISORS LLC136,609$19.0K28.2%NEW
3MORGAN STANLEY122$17.000.0%
4BANK OF AMERICA CORP /DE/42$6.000.0%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
UBS Group AGEXIT348,3120-100.0%$0.002025-Q2
UBS Group AGDOUBLED24,005348,312+1351.0%$48.4K2025-Q1
CITADEL ADVISORS LLCNEW136,609$19.0K2025-Q1

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 6.0/10.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action May 2023): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
2024-12-31
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B
3 analyst firms have rated this stock: 0 upgrades, 2 downgrades, 1 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
May 1, 2023 Brookline Capital DOWNGRADE Buy Hold
Apr 3, 2023 Maxim Group DOWNGRADE Buy Hold
Mar 3, 2021 Cantor Fitzgerald INITIATE Overweight

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20252410086%
May 1, 20252410086%
Apr 1, 20252410086%
Mar 1, 20252410086%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

Apr 28, 2026
earnings_calendar
SCPX Q4 2025 Earnings After Market Close — 2026-04-28